Technology News Journal
SEE OTHER BRANDS

Global take on science and technology news

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Technology News Journal.

MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results

MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results

TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it...

Sionna Therapeutics Reports Second Quarter 2025 Financial Results

Sionna Therapeutics Reports Second Quarter 2025 Financial Results

Announced positive Phase 1 data for SION-719 and SION-451 demonstrating both first-in-class NBD1 stabilizers were generally well tolerated and exceeded pharmacokinetic targets Initiation of Phase 2a proof-of-concept trial of SION-719 as an add-on...

BNC Accelerates Toward Global #1 BNB Treasury With $160M Purchase

BNC Accelerates Toward Global #1 BNB Treasury With $160M Purchase

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- BNB Network Company, the treasury management business of CEA Industries Inc. (Nasdaq: BNC), today announced the purchase of 200,000 BNB tokens, furthering its momentum toward becoming the largest...

FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy

FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal...

SEOPS to Include Early Spacecraft Detection and Monitoring Services with its Launch Contracts

SEOPS to Include Early Spacecraft Detection and Monitoring Services with its Launch Contracts

In an industry-first move, a partnership with Digantara delivers complementary post-launch spacecraft identification and monitoring amid rising orbital traffic SALT LAKE CITY, UT, UNITED STATES, August 11, 2025 /⁨EINPresswire.com⁩/ -- Space launch...

Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results

Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results

- Released positive topline data from the VIRAGE Phase 2b study of VCN-01 (zabilugene almadenorepvec); expanded data to be presented at the European Society for Medical Oncology (ESMO) 2025 Congress in October - - VCN-01 demonstrates potential in...

Medical Technology Platform Market Poised for Significant Growth, Forecast to Hit USD 67.26 Billion by 2032, Says Coherent Market Insights

Medical Technology Platform Market Poised for Significant Growth, Forecast to Hit USD 67.26 Billion by 2032, Says Coherent Market Insights

Burlingame, CA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The global Medical Technology Platform Market is estimated to be valued at USD 31.59 Bn in 2025 and is expected to reach USD 67.26 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of...

Wearable Devices Secures U.S. Patent for Groundbreaking Neural Interface Technology

Wearable Devices Secures U.S. Patent for Groundbreaking Neural Interface Technology

Granted Patent Covers Neural Measurement of Weight, Torque and Force with Broad Applications in Brain-Computer Interfaces, Industry 4.0 and Extended Reality YOKNEAM ILLIT, ISRAEL, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the...

Picus Security Finds 46% of Enterprise Passwords Vulnerable to Cracking — 2X Increase From 2024

Picus Security Finds 46% of Enterprise Passwords Vulnerable to Cracking — 2X Increase From 2024

SAN FRANCISCO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Picus Security, the leading security validation company, today released the Blue Report™ 2025, based on more than 160 million real-world attack simulations in live production environments. Now in...

CECO Environmental Announces Upcoming  Investor Conferences

CECO Environmental Announces Upcoming Investor Conferences

ADDISON, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announces...

True Footage and Restb.ai cut hours from the  appraisal process with AI-powered accuracy

True Footage and Restb.ai cut hours from the appraisal process with AI-powered accuracy

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- True Footage, a technology-driven appraisal and valuation company transforming home valuation nationwide, and Restb.ai, the real estate industry’s leader in AI and computer vision technology, today...

Science, Technology and Innovation host 2025 South African Women in Science Awards, 21 Aug

Science, Technology and Innovation host 2025 South African Women in Science Awards, 21 Aug

As the country marks Women's Month, the Department of Science, Technology and Innovation is pleased to announce the finalists for the 2025 South African Women in Science Awards (SAWiSA), a flagship initiative that has recognised and celebrated...

Medical Device Sterilization Market Set to Grow at an Impressive CAGR of 8.23% Through 2034 | 36.19 (USD Billion)

Medical Device Sterilization Market Set to Grow at an Impressive CAGR of 8.23% Through 2034 | 36.19 (USD Billion)

The current industry size reflects a market deeply integrated with the broader healthcare ecosystem, directly impacting patient safety and clinical outcomes US, NY, UNITED STATES, August 8, 2025 /⁨EINPresswire.com⁩/ -- Medical Device Sterilization...

Oragenics Q2 2025 Shareholder Update

Oragenics Q2 2025 Shareholder Update

Advancing Brain-First Recovery Platform Toward Clinical Milestones Pioneering Intranasal Therapeutics for Concussion SARASOTA, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering biotechnology company...

Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry

Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry

VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for...

Avicanna Announces US Patent and Trademark Office Issuance of New Patent

Avicanna Announces US Patent and Trademark Office Issuance of New Patent

USPTO Issues Patent No. US 12,343,315 B2 covering topical cannabinoid compositions for clear skin TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company...

Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update

Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update

Reported positive KT-621 (STAT6) Phase 1 healthy volunteer data surpassing Kymera’s target product profile, and further validating its oral, dupilumab-like profile KT-621 BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) patients...

HbA1c Testing Devices Market Size to Reach $4.36 Billion by 2034, Growing at 6.4% CAGR

HbA1c Testing Devices Market Size to Reach $4.36 Billion by 2034, Growing at 6.4% CAGR

The global HbA1c testing devices market was valued at approximately USD 2.34 billion in 2024 and is expected to reach around USD 4.36 billion by 2034 PUNE, MAHARASHTRA, INDIA, August 11, 2025 /⁨EINPresswire.com⁩/ -- 📊 Global HbA1c Testing Devices...

I-Mab Completes Enrollment in Planned Phase 1b Dose Expansion Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers

I-Mab Completes Enrollment in Planned Phase 1b Dose Expansion Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers

Enrollment in the planned second dose expansion cohort completed ahead of expectations Topline results expected in Q1 2026 Positive Phase 1b dose escalation data presented at ESMO GI on July 2nd ROCKVILLE, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) --...

Altimmune Board of Directors Appoints Jerry Durso as Chairman

Altimmune Board of Directors Appoints Jerry Durso as Chairman

Appointment recognizes Mr. Durso’s extensive commercial expertise as Altimmune prepares for Phase 3 development of pemvidutide in MASH Mitchel Sayare, Ph.D., to remain on the Board as Independent Director GAITHERSBURG, Md., Aug. 11, 2025 (GLOBE...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions